COVID-19 treatment sotrovimab unlikely to protect against BA.2: Health Canada – National |…
Health Canada is warning medical professionals that a COVID-19 monoclonal antibody drug is unlikely to be effective against the Omicron BA.2 sub-variant.
The country’s federal drug regulator issued a notice to health-care…